OncLive, in conjunction with The Ruesch Center for the Cure of Gastrointestinal Cancers, honored five individuals with a 2020 Luminary Award in Gastrointestinal Cancers for their commitment to the gastrointestinal cancer community.
OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with current and insightful information on patient care, in conjunction with The Ruesch Center for the Cure of Gastrointestinal (GI) Cancers, honored five individuals with a 2020 Luminary Award in GI Cancers for their commitment to the GI cancer community. The Luminary Awards in GI Cancers event recognizing this year’s honorees will take place this Fall in tandem with the 2020 Ruesch Center Symposium.
“Congratulations to the 2020 Luminary Awards in GI Cancers honorees,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of OncLive®. “All five of these individuals have influenced the field of GI cancers tremendously through research, clinical care and advocating for patients. We are so proud that we were able to collaborate with The Ruesch Center to celebrate these dedicated individuals, who make a difference every day by improving the lives of patients with gastrointestinal cancers.”
The following are the honorees for the 2020 Luminary Awards in GI Cancers:
"The Luminaries Awards is our opportunity to honor those who have set a standard for us all. Each awardee's dedication, creativity, compassion, and laser like focus on improving outcomes for GI cancer patients has translated into new standards. We give these awards to recognize their efforts and to inspire others as we continue in the fight," said John L. Marshall, MD, director, The Ruesch Center for the Cure of GI Cancers.